Elda Tagliabue - Concepedia

Author

Elda Tagliabue

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

D Delia, E Tagliabue, E. TAGLIABUE, E. Tagliabue, ELDA TAGLIABUE, Elda Tagliabue, S. Elsea, S. Menard, Tagliabue, Elda

504

Publications

16.6K

Citations

H-Index

146

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan University of Palermo University of Liège

About

Elda Tagliabue is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	85	4.9K
2	Natural Sciences	7	7	444
3	Engineering	6	6	503
4	Health Sciences	5	5	138
5	Public Health	2	2	41

Elda Tagliabue

169

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Roberto Gennari, Sylvie Ménard, Francesco Fagnoni, Clinical Cancer Research	2004	507
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy Valentina Ciravolo, Veronica Huber, Gaia C. Ghedini, Journal of Cellular Physiology Breast OncologyEndosome-derived NanovesiclesNovel TherapyExosomesMedicine	2011	498
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome Anna Bergamaschi, Elda Tagliabue, Thérese Sørlie, The Journal of Pathology Breast OncologyEngineeringPathologyGene Expression ProfilingTumor Biology	2007	383
Replacement of Fhit in cancer cells suppresses tumorigenicity Zurab Siprashvili, Gabriella Sozzi, Larry D. Barnes, Proceedings of the National Academy of Sciences	1997	367
microRNA-205 Regulates HER3 in Human Breast Cancer Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Cancer Research	2009	363
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Francesco Pezzella, Ugo Pastorino, Elda Tagliabue, PubMed	1997	330
Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity Silvia Miotti, Silvana Canevari, Sylvie Ménard, International Journal of Cancer	1987	317
Immunocytochemical markers in stage I lung cancer: relevance to prognosis. Ugo Pastorino, Salvatore Andreola, Elda Tagliabue, Journal of Clinical Oncology	1997	308
FOXP3 Expression and Overall Survival in Breast Cancer Andrea Merlo, Patrizia Casalini, Maria Luisa Carcangiu, Journal of Clinical Oncology	2009	295
Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Gabriella Sozzi, Ugo Pastorino, Luisa Moiraghi, PubMed Advanced Lung DiseaseLung InflammationImmunologyPathologyCancer Biology	1998	250

Page 1